BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)
CAPS Rating:
The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
Main Street 1; Wall Street 0
The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Value of omega 3 fatty acids from ocean getting greater recognition. Efficient extraction process